Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer (2024) Benderska-Söder N, Ecke T, Kleinlein L, Roghmann F, Bismarck E, van Rhijn BW, Stenzl A, et al. Journal article, Review article 25 years International Bladder Cancer Network (IBCN): The past, the present, and the future (2023) Dyrskjøt L, Vlahou A, Black PC, Droller M, Grossmann HB, Goebell P, Kamat AM, et al. Journal article, Review article Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma (2023) Kümmerl L, Kraulich M, Lesyuk W, Binninger A, Goebell P, Kahlmeyer A Journal article Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1 (2023) Hensley PJ, Seiler R, Herr H, Mouw KW, Iyer G, Dyrskjøt L, Nawroth R, et al. Journal article, Review article Editorial: Cutting edge basic and clinical bladder cancer research – the IBCN updates (2023) Goebell P, Kamat AM, Black PC, Dyrskjøt L, Nawroth R, Seiler R, Todenhöfer T, et al. Journal article, Review article Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany (2022) Wenzel M, Borkowetz A, Lieb V, Hoffmann MA, Borgmann H, Höfner T, Dotzauer R, et al. Journal article Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients (2022) Mertens LS, Claps F, Mayr R, Bostrom PJ, Shariat SF, Zwarthoff EC, Boormans JL, et al. Journal article IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer (2022) Christensen E, Wyatt AW, Galsky MD, Grivas P, Seiler R, Nawroth R, Goebell P, et al. Journal article, Review article Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III (2022) Reike MJ, Ingersoll MA, Müller DC, Zuiverloon TC, Strandgaard T, Kamat AM, Williams SB, et al. Journal article, Review article Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria (2022) Kuckuck EC, Hennenlotter J, Todenhöfer T, Brünn LA, Rass GC, Stenzl A, Hakenberg OW, et al. Journal article